← Eichor
Condition: Allergy And Immunology Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Allergy And Immunology

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · 51 location(s) · ADARx Pharmaceuticals, Inc. · NCT06960213Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema
Phase 3 · 32 location(s) · Pharvaris Netherlands B.V. · NCT07266805Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
Phase N/A · 9 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT06762002Allergy and Immunology Natural History Study
Phase N/A · 1 location(s) · Columbia University · NCT05584488Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in
Phase 3 · 62 location(s) · Pharvaris Netherlands B.V. · NCT06679881Immunologic Basis of Food Protein-Induced Enterocolitis Syndrome
NA · 2 location(s) · NYU Langone Health · NCT06683521LaCE (Lactobacillus Paracasei LPB27 On Early Childhood Eczema)
Phase 2 · 1 location(s) · The University of New South Wales · NCT06584552A Study to Learn About the C1-Inhibitor Function as Diagnosis for Hereditary Angioedema
NA · 1 location(s) · Takeda · NCT07293364A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) in the Kingdom of Saudi Arabia
Phase N/A · 1 location(s) · Takeda · NCT07263685Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE
Phase 2 · 4 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06919003A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)
Phase N/A · 22 location(s) · CSL Behring · NCT07001280Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients
Phase 1/Phase 2 · 1 location(s) · Institute for Asthma and Allergy · NCT07046806Donidalorsen Treatment in Children With Hereditary Angioedema
Phase 3 · 10 location(s) · Ionis Pharmaceuticals, Inc. · NCT07298447Real-life Ecological Momentary Assessment of Lived Burden in Hereditary AngioEdema
Phase N/A · 1 location(s) · Istituti Clinici Scientifici Maugeri SpA · NCT07448181Biologics And Clinical Immunology Cohort at Sinai
Phase N/A · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT04784364Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
Phase 3 · 48 location(s) · ADARx Pharmaceuticals, Inc. · NCT07428499Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg
NA · 1 location(s) · University of Rochester · NCT06260956Restoration of Microbiota in Neonates
NA · 1 location(s) · Karolinska Institutet · NCT03928431Feasibility Study of a New Immunoglobulin E (IgE) Assay Method
Phase N/A · 2 location(s) · University Hospital, Toulouse · NCT04751760Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
Phase N/A · 1 location(s) · Murdoch Childrens Research Institute · NCT05394363Bern Human Organoid-Study to Study Host-microbe Interaction
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT05323357Safety and Efficacy Study of Transplantation of Autologous CD34+ Cells Transduced With the G2ARTE Lentiviral Vector Expr
Phase 1/Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05071222Institutional Registry of Rare Diseases
Phase N/A · 1 location(s) · Hospital Italiano de Buenos Aires · NCT06573723Metabolic Profiling of Immune Responses in Immune-mediated Diseases
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04864886
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.